FIELD: medicine, pharmacy. SUBSTANCE: invention proposes a pharmaceutical preparation containing glucosidase and/or amylase inhibitor (Acarbode) as a biologically active component and an inhibitor of lipase - tetrahydrolipstatin and usual pharmaceutical vehicles. The preparation is used for treatment of patients with obesity and provides the more significant weight decrease. EFFECT: enhanced effectiveness of the preparation. 1 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF INHIBITORS OF GASTRO- INTESTINAL LIPASE | 1998 |
|
RU2201272C2 |
| TETRAHYDROLIPSTATIN-CONTAINING COMPOSITIONS | 1998 |
|
RU2170579C2 |
| PHARMACEUTICAL PREPARATION | 1994 |
|
RU2146522C1 |
| DIBENZOSUBERONE DERIVATIVES | 2005 |
|
RU2391337C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING LIPASE INHIBITOR AND GLUCOMANNAN | 2003 |
|
RU2297221C2 |
| NOVEL SPIROPENTACYCLIC COMPOUNDS | 2005 |
|
RU2360909C2 |
| DISPERSION COMPOSITION CONTAINING LIPASE INHIBITORS | 2000 |
|
RU2239428C2 |
| PREPARATION FOR TREATMENT OF PATIENTS WITH INFECTIOUS DISEASES CAUSED BY MYCOBACTERIA, ACTINOMYCES, MAINLY NOCARDIA SPECIES, AND TOXOPLASMOSIS PATHOGENS | 1994 |
|
RU2136272C1 |
| METHOD FOR PREPARING COMPOSITION | 2001 |
|
RU2244542C2 |
| DERIVATIVES OF 1,1-DIOXOTHIOMORPHOLINYLINDOLYL METHANONE FOR USE AS HISTAMINASE MODULATORS | 2006 |
|
RU2412182C2 |
